These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 34975451)

  • 1. Liraglutide Reduces Vascular Damage, Neuronal Loss, and Cognitive Impairment in a Mixed Murine Model of Alzheimer's Disease and Type 2 Diabetes.
    Carranza-Naval MJ; Del Marco A; Hierro-Bujalance C; Alves-Martinez P; Infante-Garcia C; Vargas-Soria M; Herrera M; Barba-Cordoba B; Atienza-Navarro I; Lubian-Lopez S; Garcia-Alloza M
    Front Aging Neurosci; 2021; 13():741923. PubMed ID: 34975451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Empagliflozin reduces vascular damage and cognitive impairment in a mixed murine model of Alzheimer's disease and type 2 diabetes.
    Hierro-Bujalance C; Infante-Garcia C; Del Marco A; Herrera M; Carranza-Naval MJ; Suarez J; Alves-Martinez P; Lubian-Lopez S; Garcia-Alloza M
    Alzheimers Res Ther; 2020 Apr; 12(1):40. PubMed ID: 32264944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term central pathology and cognitive impairment are exacerbated in a mixed model of Alzheimer's disease and type 2 diabetes.
    Infante-Garcia C; Ramos-Rodriguez JJ; Galindo-Gonzalez L; Garcia-Alloza M
    Psychoneuroendocrinology; 2016 Mar; 65():15-25. PubMed ID: 26708068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central vascular disease and exacerbated pathology in a mixed model of type 2 diabetes and Alzheimer's disease.
    Ramos-Rodriguez JJ; Jimenez-Palomares M; Murillo-Carretero MI; Infante-Garcia C; Berrocoso E; Hernandez-Pacho F; Lechuga-Sancho AM; Cozar-Castellano I; Garcia-Alloza M
    Psychoneuroendocrinology; 2015 Dec; 62():69-79. PubMed ID: 26254770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of liraglutide in Alzheimer's disease pathology.
    Vargas-Soria M; Carranza-Naval MJ; Del Marco A; Garcia-Alloza M
    Alzheimers Res Ther; 2021 Jun; 13(1):112. PubMed ID: 34118986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing brain glucose uptake by Gypenoside LXXV ameliorates cognitive deficits in a mouse model of diabetic Alzheimer's disease.
    Meng X; Zhang Y; Li Z; Ma G; Zhang X; Zhang D; Cao W; Wang S; Cai Q; Cui P; Huang G
    Phytother Res; 2023 Feb; 37(2):611-626. PubMed ID: 36325883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidiabetic Polypill Improves Central Pathology and Cognitive Impairment in a Mixed Model of Alzheimer's Disease and Type 2 Diabetes.
    Infante-Garcia C; Ramos-Rodriguez JJ; Hierro-Bujalance C; Ortegon E; Pickett E; Jackson R; Hernandez-Pacho F; Spires-Jones T; Garcia-Alloza M
    Mol Neurobiol; 2018 Jul; 55(7):6130-6144. PubMed ID: 29224179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive Neuronal Pathology and Synaptic Loss Induced by Prediabetes and Type 2 Diabetes in a Mouse Model of Alzheimer's Disease.
    Ramos-Rodriguez JJ; Spires-Jones T; Pooler AM; Lechuga-Sancho AM; Bacskai BJ; Garcia-Alloza M
    Mol Neurobiol; 2017 Jul; 54(5):3428-3438. PubMed ID: 27177549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell proliferation and neurogenesis alterations in Alzheimer's disease and diabetes mellitus mixed murine models.
    Hierro-Bujalance C; Del Marco A; José Ramos-Rodríguez J; Infante-Garcia C; Bella Gomez-Santos S; Herrera M; Garcia-Alloza M
    J Neurochem; 2020 Sep; 154(6):673-692. PubMed ID: 32068886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid beta and diabetic pathology cooperatively stimulate cytokine expression in an Alzheimer's mouse model.
    Sankar SB; Infante-Garcia C; Weinstock LD; Ramos-Rodriguez JJ; Hierro-Bujalance C; Fernandez-Ponce C; Wood LB; Garcia-Alloza M
    J Neuroinflammation; 2020 Jan; 17(1):38. PubMed ID: 31992349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Spontaneous Central Bleeding and Cognition Impairment in APP/PS1 Mice with Poorly Controlled Diabetes Mellitus.
    Ramos-Rodriguez JJ; Infante-Garcia C; Galindo-Gonzalez L; Garcia-Molina Y; Lechuga-Sancho A; Garcia-Alloza M
    Mol Neurobiol; 2016 May; 53(4):2685-97. PubMed ID: 26156287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
    McClean PL; Hölscher C
    Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shenqi Xingnao Granules ameliorates cognitive impairments and Alzheimer's disease-like pathologies in APP/PS1 mouse model.
    Yang CC; Jia XY; Zhang L; Li YL; Zhang ZJ; Li L; Zhang L
    Chin Herb Med; 2020 Oct; 12(4):421-429. PubMed ID: 36120170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mango leaf extract improves central pathology and cognitive impairment in a type 2 diabetes mouse model.
    Infante-Garcia C; Jose Ramos-Rodriguez J; Marin-Zambrana Y; Teresa Fernandez-Ponce M; Casas L; Mantell C; Garcia-Alloza M
    Brain Pathol; 2017 Jul; 27(4):499-507. PubMed ID: 27537110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liraglutide Protects Against Brain Amyloid-β
    Duarte AI; Candeias E; Alves IN; Mena D; Silva DF; Machado NJ; Campos EJ; Santos MS; Oliveira CR; Moreira PI
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32143329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease.
    McClean PL; Parthsarathy V; Faivre E; Hölscher C
    J Neurosci; 2011 Apr; 31(17):6587-94. PubMed ID: 21525299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin attenuates plaque-associated tau pathology and reduces amyloid-β burden in APP/PS1 mice.
    Chen Y; Zhao S; Fan Z; Li Z; Zhu Y; Shen T; Li K; Yan Y; Tian J; Liu Z; Zhang B
    Alzheimers Res Ther; 2021 Feb; 13(1):40. PubMed ID: 33563332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unexpected partial correction of metabolic and behavioral phenotypes of Alzheimer's APP/PSEN1 mice by gene targeting of diabetes/Alzheimer's-related Sorcs1.
    Knight EM; Ruiz HH; Kim SH; Harte JC; Hsieh W; Glabe C; Klein WL; Attie AD; Buettner C; Ehrlich ME; Gandy S
    Acta Neuropathol Commun; 2016 Feb; 4():16. PubMed ID: 26916443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early intervention with glucagon-like peptide 1 analog liraglutide prevents tau hyperphosphorylation in diabetic db/db mice.
    Ma DL; Chen FQ; Xu WJ; Yue WZ; Yuan G; Yang Y
    J Neurochem; 2015 Oct; 135(2):301-8. PubMed ID: 26183127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer's disease.
    McClean PL; Hölscher C
    Neuropharmacology; 2014 Nov; 86():241-58. PubMed ID: 25107586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.